Powell,
Simpson settle case with nutrition company
Send a link to a friend
[September 09, 2015]
By Kayon Raynor
KINGSTON (Reuters) - Jamaican sprinters
Asafa Powell and Sherone Simpson have settled a legal case with a
nutrition company that sold the supplement Epiphany D1 which contained
the banned substance oxilofrine, their management company said on
Tuesday.
|
Two years after testing positive for the stimulant, Powell and
Simpson have reached an out-of-court settlement with Dynamic Life
Nutrition LLC, according to a news release.
Details of the settlement were not disclosed. Efforts to contact the
supplement company for independent confirmation were unsuccessful.
The Jamaican pair tested positive for oxilofrine in June 2013 and
got 18-month bans which were later reduced on appeal to six months
by the Court of Arbitration for Sport (CAS).
Powell and Simpson, both Olympic relay champions, sued the company
for US$8 million after independent laboratory tests revealed that
there were "ingredients in the product (Epiphany D1) that were not
listed on the label".
Despite the settlement, Powell, 32, remains disappointed by what he
says is the damage done to his reputation by the positive test.
"There is no way to really explain the kind of damage a ban has on
an athlete's reputation," said the former world record holder in the
100 meters. "There's no doubt that we're going to continue the fight
to repair it and regain the trust of my fans and fans of the sport."
Simpson, a three-time Olympian, added that while the process had
been time consuming it had not affected them on the track and they
were now cautious on what they took.
"We have a very capable team, and both of us are now extra careful
about our diets and supplement regimen," she said.
[to top of second column] |
The sprinters had testified in an anti-doping disciplinary hearing
in Jamaica and a CAS appeal that they took Epiphany D1 as part of
their training regimen, but later found out that the supplement
contained the banned stimulant oxilofrine.
Powell and Simpson faced a lengthy anti-doping hearing in Jamaica,
forcing them to miss the 2013 world championships in Moscow, before
both were suspended from athletics for 18 months.
Their sanctions were later cut to six months after CAS found they
did not know the stimulant was present in Epiphany D1.
Epiphany D1 has since been placed on the U.S. Anti-Doping Agency
(USADA) high risk supplement list, warning athletes to avoid the
product.
(Editing by Andrew Both)
[© 2015 Thomson Reuters. All rights
reserved.]
Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|